Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Investigation of Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma

NCT05002621 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05002621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05002621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Investigation of Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
February 16, 2021
Completion date
December 11, 2025
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eosinophilic asthma